“borderline significance”

Also, there was a borderline significance between GRS and vitamin B9 (P-value = 0.05) and fructose (P-value = 0.05).

In the CSS subgroup analysis, the interaction between sex and treatment modality showed borderline significance ( p = 0.05).

Moreover, the positive association between baseline DBP and HbA1c decline achieved borderline significance ( β = 0.027 [95% CI: 0.0, 0.054]; p = 0.05) ( Supplementary Table S21 ).

However, borderline significance was found only for DEP score (−0.090 (95% CI: −0.186, 0.002), p = 0.05).

The OS in HCC patients with higher expression of Globo H (mean: 89.9, 95% CI: 77.3–102.5 months) was also shorter than those with lower expression of Globo H, albeit with borderline significance (mean: 112.3, 95% CI: 105.7–118.9 months; p = 0.05) [ Fig. 2 B].

18 When compared to matched controls, the genotype and allele frequencies of rs12456492 differed significantly for PD ( P = 0.001 and P = 0.007, respectively), as well as for ASD with borderline significance ( P = 0.05 and P = 0.06, respectively). 18 Polymorphisms in CD157/BST1 , another gene associated with PD, were associated with ASD as well.

7 A), IFIH1 and ISG15 showed no significant association with late-stage RA, while CXCL10 demonstrated borderline significance (OR = 2.170, P = 0.050).

Furthermore, in the CMV group, CRP gained borderline significance in the regression models as an independent predictor ( p <0.05).

However, when adjusting for covariates, none of the cohorts of interest were associated with having a statistically significant difference in ADL difficulty, although borderline significance was seen for having stage III/IV difficulty when comparing nAMD vs control (OR, 0.74; 95% CI, 0.54-1.00; P < .05) ( Figure 2 ).

ABC ≥ 0.3 × 109/L was also associated with leukocytosis (leukocyte count ≥ 11 × 109/L; p = 0.01) and increased AEC while palpable splenomegaly showed borderline significance ( p = 0.05).

Four of the studies showed the pooled estimates of mean difference in the change of HAMA scores between acupuncture plus paroxetine or duloxetine group and medication alone group were statistically significant at week 4 (−1.94, 95%CI: −3.71 to −0.17; p = 0.03) with borderline significance at week 6/8 (−3.17, 95%CI: −6.38 to 0.04; p = 0.05) from baseline.

First, the analysis of the Stage IIIA–IIIB subgroup was primarily driven by a single trial, resulting in a significant sample size imbalance between the neoadjuvant (n=88) and perioperative (n=406) arms; consequently, the borderline significance (P=0.05) should be interpreted with caution as an exploratory trend.

Only 9.4% of individuals had already been diagnosed with COVID-19 prior to the infection that caused hospitalization, with no significant difference with the presence of post-COVID-19 syndrome 6 and 12 months after hospital discharge. However, among patients who were hospitalized due to recurrent COVID-19 infection, 64.7% had three or more symptoms after six months versus 34.4% of patients who had been hospitalized due to the first infection, with a borderline significance level (p-value = 0.05); but this difference was not observed 12 months after discharge.

Septations were more frequently identified on MRI (32, 47.8%) than on USG (23, 34.3%), showing borderline significance (p = 0.05).

The delivery mode required further validation despite its borderline significance ( P = 0.05).

Among the lipid parameters, only low-density lipoproteins demonstrated borderline significance (p = 0.05) with CIMT.

Pre-op LVEF was associated with the risk of post-op respiratory failure (OR 0.97, 95% CI 0.96–0.99, p = 0.01), whereas pre-op pulmonary hypertension showed borderline significance as a predictive factor (OR 2.01, 95% CI 0.98–4.09, p = 0.05). - Wound dehiscence and delirium Our logistic regression analysis revealed obesity was not a risk factor for either wound dehiscence or delirium (OR: 1.71, 95% CI: [0.885–3.336], p = 0.11; OR: 1.03, 95% CI: [0.34–3.13], p = 0.95, respectively).

All symptoms and clinical variables showed statistically significant associations with persistent symptoms ( p < 0.05), with the exception of bronchitis, which showed a borderline significance ( p = 0.05), indicating that these factors are meaningfully related to the persistence of symptoms beyond four weeks.

Overall, PNP and NNP patients had a median of 5 neurologic manifestations or symptoms attributed to PASC, with significant age-related differences in PNP patients (median [IQR] number of symptoms: younger 6 [4–8], middle-age 5 [3–7], older 4 [2–6]; p = 0.001) and borderline significance in NNP patients (median [IQR] number of symptoms: younger 5 [3–7], middle-age 5 [3–7], older 4 [3–6]; p = 0.05), reflecting a lower number of neurologic symptoms in older patients.

Levels of p < 0.05 were assumed significant and labeled by an asterisk in the graphs, and borderline significance with p ≈ 0.05 is indicated by a hash symbol; non-significance by n.s. 3.

The education level exhibits borderline significance (p=0.05), suggesting a potential weak correlation, as people possessing a diploma or secondary education demonstrate marginally elevated mean values relative to those with higher educational attainment.

It significantly outperformed two ocular oncology fellows ( p = 0.02 and 0.03, respectively) and demonstrated borderline significance compared to a senior ophthalmologist ( p = 0.05).

In multivariable logistic regression analysis, SUVmax remained independently associated with grade 3 [odds ratio (OR) 1.25, 95% confidence interval (CI): 1.13–1.38, P<0.001], whereas 3D-CTR showed only borderline significance (OR 1.01, 95% CI: 1.00–1.02, P=0.050).

There was borderline significance within‐sample variance for Bray–Curtis dissimilarity by location ( F = 2.05, p = 0.05) and significant within‐sample variance when comparing by cohort ( F = 7.37, p = 9.00e‐3), but not sex ( F = 0.06, p = 0.80) suggesting that significant results may be driven by within‐group variation by cohort and individual locations.

gondii seropositivity was higher in patients with reflex impairment (27.8%) than patients without this impairment (8.8%), and this difference showed a borderline significance ( P = 0.05).